Skip to content
No picture yet

Apo-Nilotinib 200 mg – DIN 02550903

Apo-Nilotinib is Nilotinib Hydrochloride Monohydrate 200 mg (capsule), sold in Canada. It is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors. It is supplied by Apotex Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Nilotinib Hydrochloride Monohydrate 200 mg

Brand
Apo-Nilotinib
Strength
200 mg
Used for
Accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors
Form
Capsule
Manufacturer
Apotex Inc
Drug class
Cancer medicine (kinase inhibitor)
Sold in
Canada
DIN
02550903

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Nilotinib pills and guides

What is Nilotinib used for?

Nilotinib is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Adult Patients With Newly Diagnosed Ph+ CML-CP

Nilotinib Capsules is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.

Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

Adult Patients With Resistant or Intolerant Ph+ CML-CP and CML-AP

Nilotinib Capsules is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib.

Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

From the FDA-approved label on DailyMed (published Sep 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02550903.
  • It names Apo-Nilotinib, Nilotinib Hydrochloride Monohydrate 200 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Apo-Nilotinib by Apotex Inc.

In Canada: prescription only.

Ingredients

Active: Nilotinib (Nilotinib Hydrochloride Monohydrate)

Other Nilotinib pills